drugset
drugset / Trial / NCT06846086

Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy

NCT06846086 ↗

Phase 3 Recruiting 46 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of current study is to: Evaluate the cardioprotective effects of melatonin in patients with cardiomyopathy.

Timeline

Start
2025-02-20
Primary completion
2026-01-01
Completion
2026-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 10 mg —

Indications

cardiomyopathy